

Over 60 years, Dr. Raphael Mechoulam has conducted pioneering research on how tetrahydrocannabinol (THC) interacts with the human endocannabinoid system.
Synopsis
Over 60 years, Dr. Raphael Mechoulam has conducted pioneering research on how tetrahydrocannabinol (THC) interacts with the human endocannabinoid system.
Synopsis
Dr. Raphael Mechoulam, a Nobel Prize nominee, conducts research in Israel on the chemistry of cannabis. His work focuses on tetrahydrocannabinol (THC) and its interaction with the endocannabinoid system, the largest receptor system in the human body. Mechoulam's findings challenge long-held beliefs about cannabis and reveal its potential therapeutic applications. Growing up in Bulgaria during the Holocaust, he has dedicated his career to advancing the understanding of cannabis and its implications for human health.
Deep Dive
Why Watch
- Meet Dr. Raphael Mechoulam, a cannabis research pioneer.
- Find out how THC interacts with the human body.
- See the impact of cannabis on health and biology.
Did You Know
- Dr. Raphael Mechoulam is a Nobel Prize nominee.
- Mechoulam grew up in Bulgaria during the Holocaust.
- The endocannabinoid system is the largest receptor system in the human body.
- Mechoulam's work has advanced the understanding of human health.
Perfect For
Frequently Asked Questions
Who is Dr. Raphael Mechoulam?
Dr. Raphael Mechoulam is a Nobel Prize nominee and a pioneering figure in cannabis research, known for his work on the chemistry and biology of cannabis.
What significant system does THC interact with?
Tetrahydrocannabinol (THC) interacts with the endocannabinoid system, which is the largest receptor system in the human body.
What was Dr. Mechoulam's background before his research?
Dr. Mechoulam grew up in Bulgaria during the Holocaust and later immigrated to Israel.
What are people saying?
Play More Like This
Browse more like this
Related Films
Is this your film?
If you made this film or hold the rights to it, we'd like to talk. We can license it and pay you a share of what it earns.

































Comments